Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer.
Int J Radiat Oncol Biol Phys
; 92(2): 390-8, 2015 Jun 01.
Article
em En
| MEDLINE
| ID: mdl-25754628
ABSTRACT
PURPOSE:
To investigate the potential of low-dose cyclophosphamide (LD-CTX) and anti-CD25 antibody to prevent activation of regulatory T cells (Tregs) during radiation therapy. METHODS AND MATERIALS We used LD-CTX and anti-CD25 monoclonal antibody as a means to inhibit Tregs and improve the therapeutic effect of radiation in a mouse model of lung and colon cancer. Mice were irradiated on the tumor mass of the right leg and treated with LD-CTX and anti-CD25 antibody once per week for 3 weeks.RESULTS:
Combined treatment of LD-CTX or anti-CD25 antibody with radiation significantly decreased Tregs in the spleen and tumor compared with control and irradiation only in both lung and colon cancer. Combinatorial treatments resulted in a significant increase in the effector T cells, longer survival rate, and suppressed irradiated and distal nonirradiated tumor growth. Specifically, the combinatorial treatment of LD-CTX with radiation resulted in outstanding regression of local and distant tumors in colon cancer, and almost all mice in this group survived until the end of the study.CONCLUSIONS:
Our results suggest that Treg depletion strategies may enhance radiation-mediated antitumor immunity and further improve outcomes after radiation therapy.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
6_ODS3_enfermedades_notrasmisibles
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T Reguladores
/
Neoplasias do Colo
/
Antineoplásicos Alquilantes
/
Ciclofosfamida
/
Subunidade alfa de Receptor de Interleucina-2
/
Imunossupressores
/
Neoplasias Pulmonares
Limite:
Animals
Idioma:
En
Revista:
Int J Radiat Oncol Biol Phys
Ano de publicação:
2015
Tipo de documento:
Article